Season 1 Episode 15: Listening Session: Recovery Continuum & Recurrence Prevention Strategies cover art

Season 1 Episode 15: Listening Session: Recovery Continuum & Recurrence Prevention Strategies

Season 1 Episode 15: Listening Session: Recovery Continuum & Recurrence Prevention Strategies

Listen for free

View show details

About this listen

In this powerful episode of The NOCE Dose, we dive deep into the stigma surrounding Substance Use Disorder (SUD) and its profound impact on People Who Use Drugs (PWUD) communities seeking treatment. Hosted by Bianca D. McCall, LMFT, this Listening Session brings together a diverse panel of experts and advocates dedicated to fostering recovery-friendly spaces in both the workplace and community.

Bianca, alongside a dynamic group of panelists, including Cheryl Nixon, Daniel Fred, Rhonda Fairchild, and Teresa Sands, explore strategies for challenging and reducing stigma, creating environments that encourage individuals to seek help, and sustaining long-term recovery.

Listeners will gain insight into evidence-based recurrence prevention strategies, and how these can be applied to today’s PWUD communities. The panel also highlights the importance of creating recovery-friendly spaces—how these spaces contribute to sustained recovery, reduce stigma, and promote inclusivity.

Join us for this insightful conversation as we explore innovative ways to support individuals on their recovery journey and advocate for systemic change in mental health and addiction care.

This episode is a must-listen for anyone invested in reducing stigma, fostering recovery-friendly environments, and promoting lasting change in addiction treatment and support.


Funding for this activity was made possible in whole or in part by the Nevada Department of Health and Human Services (DHHS) Director’s Office through the Fund for a Resilient Nevada, established in Nevada Revised Statutes 433.712 through 433.744. The opinions, findings, conclusions, and recommendations expressed in this podcast are those of the author(s) and do not necessarily represent the official views of the Nevada Opioid Center of Excellence or its funders.

No reviews yet